85
Views
3
CrossRef citations to date
0
Altmetric
Case Report

PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report

, ORCID Icon, , , , ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 3921-3928 | Published online: 29 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giorgio Bogani, Innocenza Palaia, Giorgia Perniola, Federica Tomao, Antonella Giancotti, Daniele Di Mascio, Giuseppe Capalbo, Ludovico Muzii, Pierluigi Benedetti Panici & Violante Di Donato. (2023) An update on current pharmacotherapy for vulvar cancer. Expert Opinion on Pharmacotherapy 24:1, pages 95-103.
Read now

Articles from other publishers (2)

Tali Pomerantz, Nicole J. Rubin, Anthony N. Karnezis, Xiao Zhao & Rebecca Brooks. (2023) Primary clear cell carcinoma of the vulva: A case report. Gynecologic Oncology Reports 50, pages 101283.
Crossref
Karina Cereceda, Nicolas Bravo, Roddy Jorquera, Roxana González-Stegmaier & Franz Villarroel-Espíndola. (2022) Simultaneous and Spatially-Resolved Analysis of T-Lymphocytes, Macrophages and PD-L1 Immune Checkpoint in Rare Cancers. Cancers 14:11, pages 2815.
Crossref